Table 4

Benefits and drug costs over 1-year to a practice population of 10,000 resulting from the introduction of these treatments assuming the incremental benefit of the drugs

Number Needed to Treat (NNT)

Number to be Treated in your Population (NTP)

Number of Events Prevented in your Population (NEPP)

Total drug cost (€)

Drug cost per death prevented (€)

MI

ACE-I

69

53

0.76

5,292

6,944

BB

48

84

1.74

3,793

2,174

Statin

53

120

2.26

46,150

20,423

Aspirin

93

37

0.40

410

1,019

MI + CHF

ACE-I

23

3

0.15

336

2,299

BB

16

9

0.55

406

739

Spironolactone

11

12

1.00

1,663

1,655

MI myocardial Infarction CHF Heart Failure ACE-I ACE Inhibitor BB beta blocker

Heller et al. BMC Public Health 2003 3:7   doi:10.1186/1471-2458-3-7